Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 0
No TA breakdown available.
R&D Momentum
52/100
Pipeline Velocity
37/100
Trial Completion Rate
96/100
Pipeline Concentration
100/100
Pipeline Freshness
97/100
Activity
Last 14 days
Effect of Scenario-Based Simulation on Clinical Learning, Confidence and Satisfaction of Midwifery Students in Management of Eclampsia Crisis in Labor
The Effect of Virtual Reality Glasess Application on Pain and Anxiety in Women Undergoing Endometrial Biopsy:A Randomized Controlled Research
''Investigation of the Effect of Benson Relaxation Technique Applied to Pregnant Women on Fear of Childbirth, Anxiety and Stress Levels of Pregnant Women''
Interleukin-6 and Cortisol Responses Following Short- and Long-Term Cycling Tests in Team Athletes With Different Cardiorespiratory Fitness Levels
Efficacy of the Serratus Posterior Superior Intercostal Plane Block for Postoperative Acute Pain Management in Open-Heart Surgery
Assessment of Artificial Intelligence Algorithms for ROTEM Analysis in Coagulation Management
Comparison of Hemodynamic and Pulmonary Outcomes Between Single-Step and Stepwise Lung Recruitment Maneuvers After Cardiopulmonary Bypass: A Randomized Controlled Trial
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)